08.00-09.00 Registration
09.00-09.10 Opening
Session I – Chairmen: Elissaveta Naumova, Amal Bishara
09.10-09.40 Interpretation of GWAS findings in transplant outcome studies
Mehmet Tevfik DORAK, Liverpool, United Kingdom
09.40-9.55 Role of H&I laboratory in Cord blood transplantation – standards, accreditation and beyond
Elissaveta Naumova, Sofia, Bulgaria
9.55-10.10 The role of non-HLA genes in HSCT outcome
Katerina Tarassi, Athens,Greece
10.10-10.25 HLA and KIR gene analysis as a predictive tool for the HSCT outcome
Svetlana Vojvodić, Novi Sad, Serbia
10.25-10.40 Unrelated Stem Cell Transplantation – novel cell therapy in the treatment of heme malignancies in Clinical Institute „Fundeni”
Daniel Coriu, Bucharest, Romania
10.40-11.10 Coffee break